Gemtuzumab Oz Ozogamicin represents a novel breakthrough in the treatment of aggressive blood malignancy, particularly relapsed leukemic cancer (AML). This novel conjugate pairs a monoclonal protein specific to the https://janeiwst128044.wikiexpression.com/user